CDC withdraws EUA for it’s PCR test

On July 21, 2021, the CDC announce they will withdraw their request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel effective December 31, 2021.  This test was first introduced in February 2020 for detection of SARS-CoV-2 only.

This PCR test was used to diagnose COVID-19 “cases” in 2020, justifying the need for a vaccine. [1]

A month earlier in May 2021 a FOIA revealed that the CDC’s PCR tests were “poorly designed and came with erroneous instructions that made it doubly difficult for labs to rely on the test’s results” and the CDC lab scientists knew that the tests failed 33% of the time yet didn’t stop it’s release.